High potency, fast acting, long lasting: Opticann’s CB4 Relief are amber-coloured oral softgel capsules, providing medical patients with a fast-acting, high-potency CBD option combined with beta caryophyllene for synergy with 4x the CBD absorption of other typical softgels. They also have 4x higher potency (based on peak absorption) and 3x faster onset (faster time to reach peak) versus most other oral CBD products (see below for graphs and clinical data). CB4 Relief softgels from Opticann contain 25mg of CBD, and 13mg of beta-caryophyllene (BCP) per capsule. These two ingredients are reported to act on the cannabinoid receptors in the endocannabinoid system. CB4 Relief softgels are THC free and are suitable for use for most patients any time of the day.
These innovative CBD softgel capsules are formulated with patented VESIsorb® technology for increased and consistent bioavailability, offering maximum and safe CBD absorption when taken orally. VESIsorb® is used to maintain the quality and stability of your medical cannabis.
What is VESIsorb®? A lipid-based formulation system, VESIsorb® is a patented collection of natural, water-soluble ingredients used in the pharmaceutical industry. There are peer-reviewed published clinical studies that show orally administered CBD is absorbed faster and to a greater extent with VESIsorb® than usual products made with MCT oil.CBD 25 mg VESIsorb® formulations can result in 4x the potency (i.e. equivalent to 100 mg of other CBD capsules).

Benefits of oral capsules:
• Consistent and long-lasting effect
• Avoid the by-products of inhalants
• Portable and easy-to-swallow
• Standardized, precision dosage

Reference:

[1] Knaub K, et al. “A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects.” Molecules, vol.24, no.2964, 2019. https://pubmed.ncbi.nlm.nih.gov/31426272/

Modinger, Yvonne et al, Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS) Molecules 2022, 27(9), 2860; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104399
Each CB4 Relief softgel contains: Cannabis Sativa Extract 25 mg CBD, 13 mg Beta-Caryophyllene, Vitamin E Dimer Derivative, Mono and Diglycerides, Fatty Acids, Natural Flavours, Gelatin (bovine), Glycerine, Carob, Water. They are gluten-free and non-GMO.